Az Üzleti Sajtószolgálat (Original Text Service - OTS) üzleti vállakozások, cégek, intézmények közleményeit, tájékoztatóit, meghívóit, állásfoglalásait közli. Szolgáltatásunk segítségével több mint 2000 újságírót és kommunikációs szakembert érhet el könnyen, gyorsan és költséghatékonyan – az Ön által megfogalmazott sajtóközleményt változtatás nélkül juttatjuk el az MTI-előfizetők szerkesztőségi rendszerébe vagy igény szerint akár a külföldi sajtóhoz is. (Az OTS anyagai nem képezik az MTI-kiadás részét, a szó szerint továbbított szövegekért minden esetben a közlő a felelős.)
|
|
|
2020. június 16., kedd 08:00 |
NEW CAPTURE THE FRACTURE® PARTNERSHIP AIMS FOR 25% REDUCTION IN THE INCIDENCE OF HIP AND VERTEBRAL FRACTURES DUE TO OSTEOPOROSIS BY 2025 (part 1) |
|
Nyon, Switzerland, June 16, 2020 (APA/OTS) - International Osteoporosis Foundation Announces First-of-its-Kind Partnership With University of Oxford, Amgen and UCB to Combat Global Public Health Burden of Osteoporosis(1) - Hip and Vertebral Fractures are Costly for Society and Can be Life-Altering for Patients2,(3) - The International Osteoporosis Foundation (IOF) has today announced a partnership with Amgen and UCB, in collaboration with the University of Oxford, to support its Capture the Fracture® program, which aims to reduce hip and vertebral fractures by 25% by 2025. Currently, it is estimated that more than 200 million people worldwide suffer from osteoporosis,(4) resulting in an osteoporosis-related fracture every three seconds.(5) |
- Cross reference: Picture is available at AP Images
(http://www.apimages.com) -
Osteoporosis is a serious chronic condition that weakens bones over
time, making them thinner and more likely to break,(5) but there are
steps patients and healthcare providers can take to reduce fracture
risk.(1) Capture the Fracture, an IOF initiative, now supported by
Amgen and UCB in collaboration with the University of Oxford, is a
global program that helps to proactively implement post-fracture
care (PFC) coordination programs in hospitals and healthcare systems
to help patients prevent subsequent fractures due to osteoporosis.
Even after an osteoporosis-related fracture approximately 80% of
individuals at high risk are still not identified or treated.(6)
"Osteoporosis remains a global concern, resulting in 8.9 million
fractures in a single year(3) and a previous fracture increases the
risk of another osteoporosis-related fracture by 86%.(7) Early
intervention through improved post-fracture identification,
diagnosis and treatment in appropriate patients can help improve
outcomes while also lessening the cost burden on healthcare
systems,"(5) said Darryl Sleep, M.D., senior vice president of
Global Medical and chief medical officer at Amgen. "Supporting
Capture the Fracture represents our proactive approach to care
designed to predict and help prevent potentially life-altering
fractures before they happen."
"We are currently witnessing a significant disease burden. As the
worldwide aging population steadily increases, it has never been
more important to address the impact that osteoporosis and
associated fractures can have on individuals," said professor Cyrus
Cooper, president of the International Osteoporosis Foundation and
professor of Musculoskeletal Science at the University of Oxford.
"We know post-fracture coordinated care implementation is the most
effective8 and efficient intervention to close the secondary
fracture prevention gap, so I'm delighted that Amgen, UCB and the
University of Oxford will support our Capture the Fracture program
as we embark on a mission to improve outcomes for patients," said
IOF chief executive officer, Dr. Philippe Halbout.
Osteoporosis is treated by multiple specialties, underscoring the
need for coordinated care to support patients with the disease. At
the core of the Capture the Fracture model is a care coordinator who
can help patients with an osteoporosis-related fracture be
identified, screened, diagnosed and appropriately treated to reduce
their future fracture risk. Post-fracture care coordination programs
have been shown to improve diagnosis and treatment rates.(8),(9)
This partnership aims to double the 390 existing Capture the
Fracture programs by the end of 2022, and will focus on key regions
including Asia Pacific, Latin America, the Middle East, and Europe.
"The introduction of the post-fracture care model is recognized as
a progressive milestone in the management of osteoporosis and
osteoporotic fractures, and remains a profound example of what good
looks like in coordination of care among multiple disconnected
players," said Professor Dr. Iris Loew-Friedrich, chief medical
officer and executive vice president, UCB. "Collaboration and cross
learning are necessary if we are to face the challenges of the
future and find a way to lessen the burden faced by healthcare
systems and people living with osteoporosis. This global partnership
supports UCB's ambition of connected healthcare, finding ways to
deliver more for the patient and transforming the lives of people
with severe diseases."
This partnership also welcomes collaboration from existing fracture
prevention coalitions on international, national and regional levels
to drive fracture prevention policy change and prioritization.
Additional elements of the partnership include developing and
implementing efficiencies and best practice sharing across PFC
program sites, creating a digital tool that documents and
communicates PFC effectiveness, and providing virtual and in-person
mentorship and learning opportunities for healthcare providers.
"Capture the Fracture is an incredible opportunity to take the
academic skills and expertise from the University to deliver real
improvements in patient care for osteoporosis," said Dr. Kassim
Javaid, associate professor, the Nuffield Department of
Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS),
University of Oxford. Dr. Javaid, along with Dr. Rafael
Pinedo-Villanueva, will be responsible for the mentorship program
and for developing care pathway and benefits calculator software for
the PFC program. "We hope that through this program millions of
lives will be changed and we look forward to working with national
and international colleagues to deliver this vision."
For more information about Capture the Fracture, visit
http://www.capturethefracture.org. (continues)
|
|
|
|
|
|
|
2020. június 16., kedd 08:00 |
NEW CAPTURE THE FRACTURE® PARTNERSHIP AIMS FOR 25% REDUCTION IN THE INCIDENCE OF HIP AND VERTEBRAL FRACTURES DUE TO OSTEOPOROSIS BY 2025 (part 2) |
|
Nyon, Switzerland, June 16, 2020 (APA/OTS) - |
About International Osteoporosis Foundation (IOF) IOF is a registered not-for-profit, non-governmental foundation
based in Switzerland. IOF has been granted Roster Consultative
Status with the Economic and Social Council of the United Nations.
IOF functions as a global alliance of patient societies, research
organizations, healthcare professionals and international companies
working to promote bone health and prevent fractures due to
osteoporosis. www.iofbonehealth.org
About Amgen Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and understand
the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its
expertise to strive for solutions that improve health outcomes and
dramatically improve people's lives. A biotechnology pioneer since
1980, Amgen has grown to be one of the world's leading independent
biotechnology companies, has reached millions of patients around the
world and is developing a pipeline of medicines with breakaway
potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical
company focused on the discovery and development of innovative
medicines and solutions to transform the lives of people living with
severe diseases of the immune system or of the central nervous
system. With 7 500 people in approximately 40 countries, the company
generated revenue of € 4.9 billion in 2019. UCB is listed on
Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news
About University of Oxford Oxford University has been placed number 1 in the Times Higher
Education World University Rankings for the fourth year running, and
at the heart of this success is our groundbreaking research and
innovation.
Oxford is world-famous for research excellence and home to some of
the most talented people from across the globe. Our work helps the
lives of millions, solving real-world problems through a huge
network of partnerships and collaborations. The breadth and
interdisciplinary nature of our research sparks imaginative and
inventive insights and solutions.
About The Nuffield Department of Orthopaedics, Rheumatology and
Musculoskeletal Sciences (NDORMS) NDORMS is a multi-disciplinary department focusing on discovering
the causes of musculoskeletal and inflammatory conditions to deliver
excellent and innovative care that improves people's quality of
life. The largest European academic department in its field, NDORMS
is part of the Medical Sciences Division of the University of Oxford
and is a rapidly growing community of more than 500 orthopaedic
surgeons, rheumatologists and scientists all working in the field of
musculoskeletal disorders. www.ndorms.ox.ac.uk
CONTACTS: International Osteoporosis Foundation: Laura Misteli, Communications Editor, +41(0)78 8571777,
lmisteli@iofbonehealth.org
NDORMS, University of Oxford: Josie Eade, Communications Officer, +44 1865 225136,
josie.eade@ndorms.ox.ac.uk
Amgen, Thousand Oaks: Megan Fox, 805-447-1423 (media) Trish Rowland, 805-447-5631 (media)
UCB: Scott Fleming, Bone Communications, UCB, +44 7702777378,
scott.fleming@ucb.com References
(1.) International Osteoporosis Foundation. IOF Compendium of
Osteoporosis 2nd Edition.
http://www.worldosteoporosisday.org/sites/default/WOD-2019/resources/compendium/2019-IOF-Compendium-of-Osteoporosis-WEB.pdf.
Accessed March 11, 2020.
(2.) Burge et al. Incidence and economic burden of
osteoporosis-related fractures in the United States, 2005-2025. J
Bone Miner Res. 2007; Mar;22 3:465-475.
(3). Johnell O, Kanis JA. An estimate of the worldwide prevalence
and disability associated with osteoporotic fractures. Osteoporos
Int. 2006;17:1726-1733.
(4.) Reginster JY, Burlet N. Osteoporosis: A still increasing
prevalence. Bone. 2006;38 (2 Suppl 1):S4-S9
(5.) International Osteoporosis Foundation. Capture The Fracture -
A global campaign to break the fragility fracture cycle (October
2012).
http://share.iofbonehealth.org/WOD/2012/report/WOD12-Report.pdf.
Accessed March 11, 2020.
(6.) Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated,
underdiagnosed and undertreated. Med J Aust. 2004;180:S18-S22.
(7.) Kanis et al. A meta-analysis of previous fracture and
fracture risk. Bone 2004 35;375-82
(8.) Akesson et al. Capture the Fracture: a Best Practice
Framework and global campaign to break the fragility fracture cycle.
Osteoporos Int. 2013 Aug;24(8):2135-52
(9.) Ganda et al. Models of care for the secondary prevention of
osteoporotic fractures: a systematic review and meta-analysis
Osteoporos Int (2013) 24:393-406
-------------------------------------------------------------------
Az OTS internetes oldalán található hírek, közlemények, fotók
a forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül
felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett
anyagot tartalmának torzítása nélkül, félreérthetőséget,
rosszindulatú következtetéseket kizáró, az eredeti
szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni.
Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI
által szó szerint továbbított tartalomért minden esetben a beadó a
felelős. © Copyright MTI nonprofit Zrt.
Az OTS szolgáltatással kapcsolatban további információt a
(06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus
levelező címen kaphat.
|
|
|
|
|
|
|
|
|
|
|